Palred Technologies Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Palred Technologies Ltd is ₹ 39.14 as of 30 Oct 15:30 . The P/E Ratio of Palred Technologies Ltd changed from 36.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Palred Technologies Ltd changed from ₹ 91.92 crore on March 2021 to ₹ 32.18 crore on March 2026 . This represents a CAGR of -16.05% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Palred Technologies Ltd for the Jun '26 is ₹ 23.06 crore as compare to the Mar '26 revenue of ₹ 23.62 crore. This represent the decline of -2.37% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Palred Technologies Ltd for the Jun '26 is ₹ 0.34 crore as compare to the Mar '26 ebitda of ₹ 0.53 crore. This represent the decline of -35.85% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Palred Technologies Ltd changed from ₹ -2.01 crore to ₹ -1.37 crore over 9 quarters. This represents a CAGR of -15.66% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Palred Technologies Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Palred Technologies Ltd

Palred Technologies Limited was formerly incorporated as Four Soft Limited in 1999.
The Company is engaged in the business of E-commerce.
It offers software solutions to the transportation and logistics sector.
It offers solutions in the areas of freight forwarding industry, 3PL logistics (3PLs), customs brokerage, contract and warehousing logistics, and liners. The software products offered by the Company include 4S eTrans, 4S eLog, 4S iLogistics, 4S Visilogplus, 4S iShipping, 4S visilog and 4S eCustoms.
Its products in freight forwarding industry include 4S eTrans, 4S Visilog iLogistics, Shipper Logistics and 4S eTrans SME. It also also offers information technology (IT)-services, including consulting, software development, system integration and implementation in the domain of logistics related IT.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Palred Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Palred Technologies Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Palred Technologies Ltd is 47 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Palred Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Palred Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Palred Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of November 1, 2026, the Palred Technologies Ltd stock price is INR ₹39.14. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Palred Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Palred Technologies Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.